Blood Bank Market Report 2026

The blood bank market size has grown strongly in recent years. It will grow from $19.12 billion in 2025 to $20.47 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing surgical and emergency care demand, expansion of hospital infrastructure, rising participation in blood donation programs, improvements in blood testing accuracy, growth of public and private blood banks.

The blood bank market size is expected to see strong growth in the next few years. It will grow to $26.59 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing investments in digital blood bank platforms, rising adoption of remote donor engagement tools, expansion of plasma collection networks, growing focus on traceability and compliance, increasing demand for efficient blood logistics. Major trends in the forecast period include increasing adoption of automated blood bank management systems, rising integration of digital donor tracking platforms, growing focus on cold chain optimization, expansion of mobile blood collection units, enhanced emphasis on quality and compliance.

A rising number of accidents is anticipated to drive the growth of the blood bank market in the coming years. The increasing frequency of accidents refers to a surge in unexpected events that result in injury, damage, or loss of life and encompasses various types of incidents, including road accidents and workplace mishaps. This rise in accidents often heightens the demand for immediate blood transfusions to treat injuries, replace lost blood, and maintain proper circulation caused by these events. For example, in October 2025, according to the European Commission, a Belgium-based executive body of the European Union responsible for proposing legislation, Iceland reported the highest increase, with a 63% rise in road fatalities in 2024 compared to 2023. Consequently, the growing number of accidents is expected to propel the blood bank market.

Key companies in the blood bank market are concentrating on developing innovative solutions, such as mixed reality applications, to address the increasing need for improved blood donation experiences and greater donor engagement. Mixed reality applications combine digital elements with the physical environment to create interactive and immersive experiences, providing a more engaging alternative to conventional blood donation methods that rely solely on in-person interactions and manual procedures. For instance, in January 2023, Abbott Laboratories, a US-based multinational medical devices and healthcare company, launched a mixed reality application integrated with Abbott technology in collaboration with Blood Centers of America, a US-based independent blood center. The application aims to enhance the blood donation process by offering an immersive digital environment that engages donors and alleviates anxiety. It helps attract new donors, particularly younger populations, by transforming donation into a more interactive and technology-driven activity. Additionally, the mixed reality tool supports blood centers by modernizing donor interactions, increasing comfort, and boosting the likelihood of repeat donations.

In December 2024, GC Biopharma Corp., a South Korea-based biopharmaceutical company, acquired ABO Holdings, Inc., for an undisclosed amount. Through this acquisition, GC Biopharma enhances its vertically integrated plasma-supply capabilities and facilitates the growth of its immunoglobulin business in the United States. ABO Holdings, Inc. is a US-based operator of plasma collection centers that provide source plasma, a vital blood component used in plasma-derived therapies.

Major companies operating in the blood bank market are American Association of Blood Banks, Blood Bank of Alaska, Canadian Blood Services, The Japanese Red Cross Society, New York Blood Center, NHS Blood And Transplant, Sanquin Blood Supply Foundation, The American Red Cross, Vitalant, America's Blood Centers, Australian Red Cross, Terumo Corporation, Haemonetics Corporation, National Blood Transfusion Council, Shire Plc, Abbott, Beckman Coulter Inc., Polymedicure, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffman La Roche, Siemens Healthcare Private Limited, BioMérieux, CSL Behring, Takeda, Octapharma, Kedrion, Macopharma, Fresenius Kabi AG, B. Braun Melsungen AG, Grifols SA, Hologic Inc., Ortho Clinical Diagnostics, Merck KGaA, Roche Diagnostics, Quotient Limited.

North America was the largest region in the blood bank market in 2025. Asia-Pacific is expected to be the fastest-growing region in the blood bank market report during the forecast period. The regions covered in the blood bank market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood bank market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the blood bank market by increasing costs of imported refrigeration units, testing equipment, consumables, transport containers, and laboratory instruments. Hospitals and blood banks in North America and Europe are most affected due to reliance on imported cold storage and testing systems, while Asia-Pacific faces higher costs in scaling collection infrastructure. These tariffs are increasing operational expenses and procurement timelines. However, they are also encouraging local manufacturing of storage equipment, regional sourcing of consumables, and modernization of domestic blood bank infrastructure.

The blood bank market research report is one of a series of new reports that provides blood bank market statistics, including blood bank industry global market size, regional shares, competitors with a blood bank market share, detailed blood bank market segments, market trends and opportunities, and any further data you may need to thrive in the blood bank industry. This blood bank market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A blood bank is a facility or organization that collects, tests, processes, and stores donated blood for use in transfusions or other medical procedures. It provides a safe and reliable source of blood for patients requiring transfusions due to surgery, injury, or medical conditions.

The primary product types of a blood bank include whole blood, red blood cells, platelets, plasma, and white blood cells. Whole blood consists of red blood cells, white blood cells, and platelets suspended in a yellow protective liquid called plasma, and it is used to treat significant blood loss, perform exchange transfusions, or for autologous blood donations. Blood banks operate through various functions such as collection, processing, testing, storage, and transportation. They can be categorized into private blood banks and public blood banks and serve multiple end-users, including hospitals, ambulatory surgical centers, clinics, and pharmaceutical companies.

The blood bank market includes revenues earned through entities by blood products derived from blood including albumin, immune globulin, specific immune globulins, and clotting factor concentrates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.